Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluca D'Onofrio

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Neuropediatrics|June 5, 2024
Reversal of Benzodiazepine-Induced Myoclonus by Flumazenil in the Neonatal Intensive Care UnitGianluca D'Onofrio, Philippe Major
Neuropediatrics|April 10, 2025
Central Vestibular Syndrome in Leber Hereditary Optic Neuropathy "Plus"Gianluca D'Onofrio, Julie Dery, Aristides Hadjinicolaou
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2024
Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medicationsGianluca D'Onofrio, Andrea Santangelo, Antonella Riva, et al.
Movement Disorders Clinical Practice|July 23, 2025
Paroxysmal Dyskinesia with a Novel Variant in the Histone 3 Family 3B (H3-3B) GeneGianluca D'Onofrio, Sebastien Perreault, Grant Mitchell, et al.
Expert Review of Neurotherapeutics|February 28, 2025
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directionsGianluca D'Onofrio, Gianmichele Villano, Giovanni Dell'isola, et al.
Expert Opinion on Pharmacotherapy|September 17, 2025
Navigating regulatory challenges in pediatric epilepsy pharmacotherapy: pathways to safe and effective treatmentsGianmichele Villano, Gianluca D'Onofrio, Antonella Riva, et al.
Epilepsia Open|September 11, 2020
Add-on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathyMathieu Kuchenbuch, Gianluca D'Onofrio, Nicole Chemaly, et al.
Clinical Nephrology. Case Studies|April 22, 2021
Influenza-associated hemolytic uremic syndrome: The pathogenic role of the virusValeria Silecchia, Gianluca D'Onofrio, Enrico Valerio, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2022
Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overviewGianluca D'Onofrio, Antonella Riva, Elisabetta Amadori, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 23, 2024
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric populationGianluca D'Onofrio, Roberta Roberti, Antonella Riva, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Neuropediatrics|June 5, 2024
Reversal of Benzodiazepine-Induced Myoclonus by Flumazenil in the Neonatal Intensive Care UnitGianluca D'Onofrio, Philippe Major
Neuropediatrics|April 10, 2025
Central Vestibular Syndrome in Leber Hereditary Optic Neuropathy "Plus"Gianluca D'Onofrio, Julie Dery, Aristides Hadjinicolaou
Expert Opinion on Drug Metabolism & Toxicology|May 29, 2024
Genetic polymorphisms of drug-metabolizing enzymes in older and newer anti-seizure medicationsGianluca D'Onofrio, Andrea Santangelo, Antonella Riva, et al.
Movement Disorders Clinical Practice|July 23, 2025
Paroxysmal Dyskinesia with a Novel Variant in the Histone 3 Family 3B (H3-3B) GeneGianluca D'Onofrio, Sebastien Perreault, Grant Mitchell, et al.
Expert Review of Neurotherapeutics|February 28, 2025
Neuromodulation as a treatment strategy in Lennox-Gastaut syndrome: evidence and future directionsGianluca D'Onofrio, Gianmichele Villano, Giovanni Dell'isola, et al.
Expert Opinion on Pharmacotherapy|September 17, 2025
Navigating regulatory challenges in pediatric epilepsy pharmacotherapy: pathways to safe and effective treatmentsGianmichele Villano, Gianluca D'Onofrio, Antonella Riva, et al.
Epilepsia Open|September 11, 2020
Add-on cannabidiol significantly decreases seizures in 3 patients with SYNGAP1 developmental and epileptic encephalopathyMathieu Kuchenbuch, Gianluca D'Onofrio, Nicole Chemaly, et al.
Clinical Nephrology. Case Studies|April 22, 2021
Influenza-associated hemolytic uremic syndrome: The pathogenic role of the virusValeria Silecchia, Gianluca D'Onofrio, Enrico Valerio, et al.
Expert Opinion on Drug Metabolism & Toxicology|August 25, 2022
Pharmacokinetic considerations surrounding the use of levetiracetam for seizure prophylaxis in neurocritical care - an overviewGianluca D'Onofrio, Antonella Riva, Elisabetta Amadori, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|March 23, 2024
Pharmacodynamic rationale for the choice of antiseizure medications in the paediatric populationGianluca D'Onofrio, Roberta Roberti, Antonella Riva, et al.
Pageof 5